keyword
https://read.qxmd.com/read/39276278/single-cell-profiling-uncovers-proliferative-cells-as-key-determinants-of-survival-outcomes-in-lower-grade-glioma-patients
#1
JOURNAL ARTICLE
Jianming Peng, Qing Zhang, Xiaofeng Zhu, Zhu Yan, Meng Zhu
Lower-grade gliomas (LGGs), despite their generally indolent clinical course, are characterized by invasive growth patterns and genetic heterogeneity, which can lead to malignant transformation, underscoring the need for improved prognostic markers and therapeutic strategies. This study utilized single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq to identify a novel cell type, referred to as "Prol," characterized by increased proliferation and linked to a poor prognosis in patients with LGG, particularly under the context of immunotherapy interventions...
September 14, 2024: Discover. Oncology
https://read.qxmd.com/read/39276262/beyond-surgical-resection-evaluating-stereotactic-brachytherapy-iodine-125-for-low-grade-gliomas-a-systematic-review-and-meta-analysis
#2
REVIEW
Lucca B Palavani, Gabriel Verly, Pedro Borges, Luis Neto, Miguel Almeida, Marianna Leite, Leonardo B Oliveira, Sávio Batista, Raphael Bertani, Allan Dias Polverini, Leonardo de Macedo Filho, Wellingson Paiva
Stereotactic Brachytherapy Iodine-125 (SBT I-125) has been investigated by some studies for the treatment of lowgrade gliomas. We performed a meta-analysis to assess the efficacy and safety of SBT I-125 Brachytherapy for treatment of patients with Low-Grade Gliomas. PubMed, Cochrane, Web of Science, and EMBASE databases were searched for randomized and observational studies. This systematic review and meta-analysis was conducted according to the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement guidelines...
September 14, 2024: Neurosurgical Review
https://read.qxmd.com/read/39276062/the-multifaceted-therapeutical-role-of-low-density-lipoprotein-receptor-family-in-high-grade-glioma
#3
REVIEW
Elisa Mastrantuono, Matilde Ghibaudi, Diana Matias, Giuseppe Battaglia
The diverse roles of the low-density lipoprotein receptor family (LDLR) have been associated with many processes critical to maintaining central nervous system (CNS) health and contributing to neurological diseases or cancer. In this review, we provide a comprehensive understanding of the LDLR's involvement in common brain tumors, specifically high-grade gliomas, emphasizing the receptors' critical role in the pathophysiology and progression of these tumors due to LDLR's high expression. We delve into LDLR's role in regulating cellular uptake and transport through the brain barrier...
September 14, 2024: Molecular Oncology
https://read.qxmd.com/read/39276052/-an-mri-multi-sequence-feature-imputation-and-fusion-mutual-aid-model-based-on-sequence-deletion-for-differentiation-of-high-grade-from-low-grade-glioma
#4
JOURNAL ARTICLE
C Wu, W Zhong, J Xie, R Yang, Y Wu, Y Xu, L Wang, X Zhen
OBJECTIVE: To evaluate the performance of magnetic resonance imaging (MRI) multi-sequence feature imputation and fusion mutual model based on sequence deletion in differentiating high-grade glioma (HGG) from low-grade glioma (LGG). METHODS: We retrospectively collected multi-sequence MR images from 305 glioma patients, including 189 HGG patients and 116 LGG patients. The region of interest (ROI) of T1-weighted images (T1WI), T2-weighted images (T2WI), T2 fluid attenuated inversion recovery (T2_FLAIR) and post-contrast enhancement T1WI (CE_T1WI) were delineated to extract the radiomics features...
August 20, 2024: Nan Fang Yi Ke da Xue Xue Bao, Journal of Southern Medical University
https://read.qxmd.com/read/39273420/cep-1347-boosts-chk2-mediated-p53-activation-by-ionizing-radiation-to-inhibit-the-growth-of-malignant-brain-tumor-cells
#5
JOURNAL ARTICLE
Yuta Mitobe, Shuhei Suzuki, Kazuki Nakamura, Yurika Nakagawa-Saito, Senri Takenouchi, Keita Togashi, Asuka Sugai, Yukihiko Sonoda, Chifumi Kitanaka, Masashi Okada
Radiation therapy continues to be the cornerstone treatment for malignant brain tumors, the majority of which express wild-type p53. Therefore, the identification of drugs that promote the ionizing radiation (IR)-induced activation of p53 is expected to increase the efficacy of radiation therapy for these tumors. The growth inhibitory effects of CEP-1347, a known inhibitor of MDM4 expression, on malignant brain tumor cell lines expressing wild-type p53 were examined, alone or in combination with IR, by dye exclusion and/or colony formation assays...
August 30, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/39273062/emerging-and-biological-concepts-in-pediatric-high-grade-gliomas
#6
REVIEW
Abigail Yoel, Shazia Adjumain, Yuqing Liang, Paul Daniel, Ron Firestein, Vanessa Tsui
Primary central nervous system tumors are the most frequent solid tumors in children, accounting for over 40% of all childhood brain tumor deaths, specifically high-grade gliomas. Compared with pediatric low-grade gliomas (pLGGs), pediatric high-grade gliomas (pHGGs) have an abysmal survival rate. The WHO CNS classification identifies four subtypes of pHGGs, including Grade 4 Diffuse midline glioma H3K27-altered, Grade 4 Diffuse hemispheric gliomas H3-G34-mutant, Grade 4 pediatric-type high-grade glioma H3-wildtype and IDH-wildtype, and infant-type hemispheric gliomas...
September 5, 2024: Cells
https://read.qxmd.com/read/39273050/pre-clinical-models-for-car-t-cell-therapy-for-glioma
#7
REVIEW
Gust Vandecandelaere, Rishab Ramapriyan, Matthew Gaffey, Leland Geoffrey Richardson, Samuel Jeffrey Steuart, Masih Tazhibi, Adrian Kalaw, Eric P Grewal, Jing Sun, William T Curry, Bryan D Choi
Immunotherapy represents a transformative shift in cancer treatment. Among myriad immune-based approaches, chimeric antigen receptor (CAR) T-cell therapy has shown promising results in treating hematological malignancies. Despite aggressive treatment options, the prognosis for patients with malignant brain tumors remains poor. Research leveraging CAR T-cell therapy for brain tumors has surged in recent years. Pre-clinical models are crucial in evaluating the safety and efficacy of these therapies before they advance to clinical trials...
September 4, 2024: Cells
https://read.qxmd.com/read/39272976/3d-bioprinted-co-cultures-of-glioblastoma-multiforme-and-mesenchymal-stromal-cells-indicate-a-role-for-perivascular-niche-cells-in-shaping-glioma-chemokine-microenvironment
#8
JOURNAL ARTICLE
Katarzyna Zielniok, Kinga Rusinek, Anna Słysz, Mieszko Lachota, Ewa Bączyńska, Natalia Wiewiórska-Krata, Anna Szpakowska, Martyna Ciepielak, Bartosz Foroncewicz, Krzysztof Mucha, Radosław Zagożdżon, Zygmunt Pojda
3D bioprinting has become a valuable tool for studying the biology of solid tumors, including glioblastoma multiforme (GBM). Our analysis of publicly available bulk RNA and single-cell sequencing data has allowed us to define the chemotactic profile of GBM tumors and identify the cell types that secrete particular chemokines in the GBM tumor microenvironment (TME). Our findings indicate that primary GBM tissues express multiple chemokines, whereas spherical monocultures of GBM cells significantly lose this diversity...
August 23, 2024: Cells
https://read.qxmd.com/read/39272914/csf1r-ligands-expressed-by-murine-gliomas-promote-m-mdscs-to-suppress-cd8-t-cells-in-a-nos-dependent-manner
#9
JOURNAL ARTICLE
Gregory P Takacs, Julia S Garcia, Caitlyn A Hodges, Christian J Kreiger, Alexandra Sherman, Jeffrey K Harrison
Glioblastoma (GBM) is the most common malignant primary brain tumor, resulting in poor survival despite aggressive therapies. GBM is characterized by a highly heterogeneous and immunosuppressive tumor microenvironment (TME) made up predominantly of infiltrating peripheral immune cells. One significant immune cell type that contributes to glioma immune evasion is a population of immunosuppressive cells, termed myeloid-derived suppressor cells (MDSCs). Previous studies suggest that a subset of myeloid cells, expressing monocytic (M)-MDSC markers and dual expression of chemokine receptors CCR2 and CX3CR1, utilize CCR2 to infiltrate the TME...
September 1, 2024: Cancers
https://read.qxmd.com/read/39272871/the-role-of-amide-proton-transfer-apt-weighted-imaging-in-glioma-assessment-of-tumor-grading-molecular-profile-and-survival-in-different-tumor-components
#10
JOURNAL ARTICLE
Gonçalo Borges de Almeida, Riccardo Pascuzzo, Francesca Mambrin, Domenico Aquino, Mattia Verri, Marco Moscatelli, Massimiliano Del Bene, Francesco DiMeco, Antonio Silvani, Bianca Pollo, Marina Grisoli, Fabio Martino Doniselli
Amide Proton Transfer-weighted (APTw) imaging is a molecular MRI technique used to quantify protein concentrations in gliomas, which have heterogeneous components with varying cellularity and metabolic activity. This study aimed to assess the correlation between the component-specific APT signal of the neoplasm and WHO grade, molecular profile and survival status. Sixty-one patients with adult-type diffuse gliomas were retrospectively analyzed. APT values were semi-automatically extracted from tumor solid and, whenever present, necrotic components...
August 29, 2024: Cancers
https://read.qxmd.com/read/39272834/recent-treatment-strategies-and-molecular-pathways-in-resistance-mechanisms-of-antiangiogenic-therapies-in-glioblastoma
#11
REVIEW
Md Ataur Rahman, Meser M Ali
Malignant gliomas present great difficulties in treatment, with little change over the past 30 years in the median survival time of 15 months. Current treatment options include surgery, radiotherapy (RT), and chemotherapy. New therapies aimed at suppressing the formation of new vasculature (antiangiogenic treatments) or destroying formed tumor vasculature (vascular disrupting agents) show promise. This study summarizes the existing knowledge regarding the processes by which glioblastoma (GBM) tumors acquire resistance to antiangiogenic treatments...
August 27, 2024: Cancers
https://read.qxmd.com/read/39272133/glucose-metabolism-in-glioma-an-emerging-sight-with-ncrnas
#12
REVIEW
Jun Rong, Qifu Wang, Tingzheng Li, Jin Qian, Jinchao Cheng
Glioma is a primary brain tumor that grows quickly, has an unfavorable prognosis, and can spread intracerebrally. Glioma cells rely on glucose as the major energy source, and glycolysis plays a critical role in tumorigenesis and progression. Substrate utilization shifts throughout glioma progression to facilitate energy generation and biomass accumulation. This metabolic reprogramming promotes glioma cell proliferation and metastasis and ultimately decreases the efficacy of conventional treatments. Non-coding RNAs (ncRNAs) are involved in several glucose metabolism pathways during tumor initiation and progression...
September 13, 2024: Cancer Cell International
https://read.qxmd.com/read/39272024/energy-metabolism-related-glud1-contributes-to-favorable-clinical-outcomes-of-idh-mutant-glioma
#13
JOURNAL ARTICLE
Renzhi Deng, Jianying Qin, Lei Wang, Haibin Li, Ning Wen, Ke Qin, Jianhui Dong, Jihua Wu, Dandan Zhu, Xuyong Sun
BACKGROUND: Glioma is the most common brain tumor. IDH mutations occur frequently in glioma, indicating a more favorable prognosis. We aimed to explore energy metabolism-related genes in glioma to promote the research and treatment. METHODS: Datasets were obtained from TCGA and GEO databases. Candidate genes were screened by differential gene expression analysis, then functional enrichment analysis was conducted on the candidate genes. PPI was also carried out to help determine the target gene...
September 13, 2024: BMC Neurology
https://read.qxmd.com/read/39271985/a-novel-approach-to-the-analysis-of-overall-survival-os-as-response-with-progression-free-interval-pfi-as-condition-based-on-the-rna-seq-expression-data-in-the-cancer-genome-atlas-tcga
#14
JOURNAL ARTICLE
Bo Lin, Kaipeng Wang, Yuan Yuan, Yueguo Wang, Qingyuan Liu, Yulan Wang, Jian Sun, Wenwen Wang, Huanli Wang, Shusheng Zhou, Kui Jin, Mengping Zhang, Yinglei Lai
BACKGROUND: Overall Survival (OS) and Progression-Free Interval (PFI) as survival times have been collected in The Cancer Genome Atlas (TCGA). It is of biomedical interest to consider their dependence in pathway detection and survival prediction. We intend to develop novel methods for integrating PFI as condition based on parametric survival models for identifying pathways associated with OS and predicting OS. RESULTS: Based on the framework of conditional probability, we developed a family of frailty-based parametric-models for this purpose, with exponential or Weibull distribution as baseline...
September 13, 2024: BMC Bioinformatics
https://read.qxmd.com/read/39271911/machine-learning-algorithms-for-predicting-glioma-patient-prognosis-based-on-cd163-fpr3-macrophage-signature
#15
JOURNAL ARTICLE
Quanwei Zhou, Xuejun Yan, Youwei Guo, Xingjun Jiang, Tuo Cao, Yiquan Ke
Tumor-associated macrophages (TAMs) play a vital role in glioma progression and are associated with poor outcomes in glioma patients. However, the specific roles of different subpopulations of TAMs remain poorly understood. Two distinct cell types, glioma and myeloid cells, were identified through single-cell sequencing analysis in gliomas. Within the TAMs-associated weighted gene co-expression network analysis (WGCNA) module, FPR3 emerged as a hub gene and was found to be expressed on CD163+ macrophages, while also being associated with clinical outcomes...
September 13, 2024: NPJ Precision Oncology
https://read.qxmd.com/read/39271837/fda-approves-first-idh-targeted-glioma-drug
#16
(no author information available yet)
No abstract text is available yet for this article.
September 2024: Nature Biotechnology
https://read.qxmd.com/read/39271535/recent-advances-in-anticancer-mechanisms-of-molecular-glue-degraders-focus-on-rbm39-dgrading-synthetic-sulfonamide-such-as-indisulam-e7820-tasisulam-and-chloroquinoxaline-sulfonamide
#17
REVIEW
Ji Hoon Jang, Joo-Young Kim, Tae-Jin Lee
Synthetic sulfonamide anticancer drugs, including E7820, indisulam, tasisulam, and chloroquinoxaline sulfonamide, exhibit diverse mechanisms of action and therapeutic potential, functioning as molecular glue degraders. E7820 targets RBM39, affecting RNA splicing and angiogenesis by suppressing integrin α2. Phase I studies have demonstrated some stability in advanced solid malignancies; however, further efficacy studies are required. Indisulam causes G1 cell cycle arrest and delays the G1/S transition by modulating splicing through RBM39 degradation via DCAF15...
September 13, 2024: Genes & Genomics
https://read.qxmd.com/read/39271260/deep-learning-based-multimodal-spatial-transcriptomics-analysis-for-cancer
#18
REVIEW
Pankaj Rajdeo, Bruce Aronow, V B Surya Prasath
The advent of deep learning (DL) and multimodal spatial transcriptomics (ST) has revolutionized cancer research, offering unprecedented insights into tumor biology. This book chapter explores the integration of DL with ST to advance cancer diagnostics, treatment planning, and precision medicine. DL, a subset of artificial intelligence, employs neural networks to model complex patterns in vast datasets, significantly enhancing diagnostic and treatment applications. In oncology, convolutional neural networks excel in image classification, segmentation, and tumor volume analysis, essential for identifying tumors and optimizing radiotherapy...
2024: Advances in Cancer Research
https://read.qxmd.com/read/39271074/impact-of-psychiatric-disorders-on-the-risk-of-glioma-mendelian-randomization-and-biological-annotation
#19
JOURNAL ARTICLE
Yanmei Qiu, Guohao Liu, Jingwen Li, Daquan Zhou, Yang Liu, Zhongyin Guo, Fan Ye, Feng Chen, Peng Peng
BACKGROUND: The conflicting results about the relationship between certain psychiatric disorders and glioma has been reported in previous studies. Moreover, little is known about the common pathogenic mechanism between psychiatric symptoms and glioma. This study aims to find out mental disorders related etiology of glioma and to interpret the underlying biological mechanisms. METHODS: A panel of SNPs significantly associated with eight psychiatric disorders (ADHD, SCZ, Insomnia, NEU, MDD, MI, BIP, and SWB) were identified as exposure related genetic instruments...
September 11, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/39271035/tomentediline-a-a-isoquinoline-alkaloids-with-undescribed-carbon-skeleton-from-corydalis-tomentella
#20
JOURNAL ARTICLE
Kunqi Zong, Zhijin Hao, Quanyou Wang, Yanan Liang, Changwei Zheng, Kaicheng Du, Fengming Ren, Yumeng Wang, Dali Meng
Two undescribed isoquinolines (1-2), including one undescribed carbon skeleton isoquinoline together with six known ones (4-9) as well as an undescribed amide (3) and three known ones (10-12) were isolated from C. tomentella. Their planar structures and absolute configurations were elucidated by extensive analyses of UV, NMR, HRESIMS, DP4+ statistical analysis and ECD calculations, respectively. Tomentediline A (1) is an isoquinoline alkaloid dimer that forms an undescribed carbon carbon bond at the C-13 position of (2H)-protoberberine in a natural product discovered for the first time...
September 11, 2024: Phytochemistry
keyword
keyword
203
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.